TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.2769
+0.0015 (0.54%)
At close: Oct 7, 2026, 4:00 PM EDT
0.2824
+0.0055 (1.99%)
After-hours: Oct 7, 2026, 7:30 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $18.77 million as of October 7, 2026. That makes TScan Therapeutics the world's 37,653rd most valuable company and 5,300th in the United States. Its market cap has decreased by 83.87% in one year.
Market Cap
18.77M
Enterprise Value
9.51M
1-Year Change
-83.87%
Global Rank
Country Rank
#5,300 United States
Category
ChartMarket Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $18.77M, a decrease of -94.77%. That is a compound annual growth rate of -43.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 18.77M | -66.93% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 20.47M |
| Psyence Biomedical | 19.03M |
| Jasper Therapeutics | 18.99M |
| Akari Therapeutics, | 18.74M |
| Estrella Immunopharma | 18.56M |
| Neuphoria Therapeutics | 18.51M |
| Lipocine | 18.22M |
| NewcelX | 17.67M |